CYDY CytoDyn Inc

Price (delayed)

$5.00

Market cap

$2.99B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.33

Enterprise value

$3.01B

Sector: Healthcare
Industry: Biotechnology

Highlights

CytoDyn's equity has surged by 52% YoY
CYDY's quick ratio is up by 4.2% QoQ
CytoDyn's net income has shrunk by 172% YoY and by 14% QoQ
The EPS has dropped by 94% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of CYDY
Market
Shares outstanding
598.13M
Market cap
$2.99B
Enterprise value
$3.01B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$151.19M
EBITDA
-$149.18M
Free cash flow
-$108.05M
Per share
EPS
-$0.33
Free cash flow per share
-$0.19
Book value per share
-$0.01
Revenue per share
$0
TBVPS
$0.23
Balance sheet
Total assets
$143.76M
Total liabilities
$150.3M
Debt
$51.07M
Equity
-$6.53M
Working capital
$15.06M
Liquidity
Debt to equity
-7.82
Current ratio
1.13
Quick ratio
0.25
Net debt/EBITDA
-0.15
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-195%
Return on equity
N/A
Return on invested capital
-2,019%
Return on capital employed
-539.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CYDY stock price

How has the CytoDyn stock price performed over time
Intraday
-1.57%
1 week
-5.48%
1 month
-16.67%
1 year
371.7%
YTD
-7.24%
QTD
-7.24%

Financial performance

How have CytoDyn's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$99.97M
Net income
-$159.18M
Gross margin
N/A
Net margin
N/A
CytoDyn's net income has shrunk by 172% YoY and by 14% QoQ
The operating income has dropped by 94% year-on-year and by 14% since the previous quarter

Growth

What is CytoDyn's growth rate over time

Valuation

What is CytoDyn stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 94% year-on-year and by 6% since the previous quarter
CytoDyn's equity has surged by 52% YoY

Efficiency

How efficient is CytoDyn business performance
The company's return on assets rose by 35% YoY and by 30% QoQ

Dividends

What is CYDY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYDY.

Financial health

How did CytoDyn financials performed over time
CYDY's total assets is 4.3% smaller than its total liabilities

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.